We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Completion of a “First in Human” Clinical Phase I Study Using CAP® Cells

News   Nov 05, 2013

 
Completion of a “First in Human” Clinical Phase I Study Using CAP® Cells
 
 
 

RELATED ARTICLES

Breast Cancers Enlist the Help of Normal Cells to Help Them Spread & Survive

News

Researchers have shown that triple negative breast tumours - which are the most aggressive and have the fewest treatment options - might one day be treated with a drug that cuts the 'phone lines' between normal cells and tumour cells.

READ MORE

Ebola Vaccine Progress and Shortfalls Highlighted

News

Despite promising advances, important scientific questions remain unanswered in the effort to develop a safe and effective Ebola vaccine.

READ MORE

Tdap Vaccination for Pregnant Women Does Not Increase Risk of Autism, Finds Study

News

A Kaiser Permanente study of more than 80,000 children born over a 4-year period showed that the prenatal Tdap vaccination (tetanus, diphtheria, acellular pertussis) was not associated with increased risk of autism spectrum disorder in children.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE